A recent systematic review of case reports of adverse events linked to GLP-1R agonists highlighted cases of pancreatitis associated with liraglutide and exenatide, although none with semaglutide (47)
New offerings include Estriol Face Cream and hormone replacement therapies such as Transdermal Estradiol Patches, Oral Micronized Progesterone Capsules, and Provera Tablets
This is the same pathway that pharmaceutical GLP-1 receptor agonists like semaglutide use, though at dramatically different intensities
It turns available glucose into energy, improving energy performance, which may be beneficial for type 2 diabetes and insulin resistance
If your current clinician lacks knowledge about these options, find one who does
The dosages used in the RCTs that showed benefits ranged from 600 to 2700 mg per day for 412 weeks